Author

Moritz F. Eissmann

La Trobe UniversityORCID 0000-0002-2855-0616Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:mouse· 2 Research Focus:benchmarking· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:differential expression· 1

Frequent Co-Authors

Ashleigh R. PohiD· 2 shared Matthias ErnstiD· 2 shared Michael BüchertiD· 2 shared Alex BoussioutasiD· 1 shared Amr H. AllamiD· 1 shared Anne Huber· 1 shared Christine Dijkstra· 1 shared Daniele V. F. TaurielloiD· 1 shared

Activity by Year

2024-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 39 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Ashleigh R. PohORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Circulating inflammatory ILC2s as a biomarker of gastric cancer progression

Ryan N. O’Keefe, Kiruthiga Raghunathan, Moritz F. Eissmann, David Baloyan, Ashleigh R. Poh, Megan O'Brien, Edgar Clapdorp, Shoukat Afshar‐Sterle, Richard M. Locksley, Matthias Ernst, Michael Büchert

This study identifies circulating inflammatory ILC2s as a biomarker for gastric cancer progression, showing their association with disease severity and potential for early detection.

bioRxiv · May 1, 2026 · PreprintCancer Biology

Mutant TP53 switches therapeutic vulnerability during gastric cancer progression within Interleukin-6 family cytokines

Anne Huber, Amr H. Allam, Christine Dijkstra, Stefan Thiem, Jennifer Huynh, Ashleigh R. Poh, Joshua Konecnik, Saumya P. Jacob, Rita A. Busuttil, Yang Liao, David Chisanga, Wei Shi, Mariah Alorro, Stephen Forrow, Daniele V. F. Tauriello, , Moritz F. Eissmann

This study identifies IL6/STAT3 signaling as a therapeutic target for TP53-mutant gastric cancer by showing its role in metastatic progression driven by mutant Trp53.

Cell Reports · Aug 1, 2024Peer-reviewedCancer Biology